↓ Skip to main content

Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries

Overview of attention for article published in Diabetes Therapy, November 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
18 Mendeley
Title
Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
Published in
Diabetes Therapy, November 2014
DOI 10.1007/s13300-014-0087-6
Pubmed ID
Authors

Victoria Divino, Mitch DeKoven, Shawn Hallinan, Nebibe Varol, Sara Bruce Wirta, Won Chan Lee, Matthew Reaney

Abstract

The objective of this study was to evaluate real-world treatment patterns of type 2 diabetes (T2D) patients initiating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Germany (GE), the United Kingdom (UK), France (FR), the Netherlands (NE), Belgium (BE), and Sweden (SE).

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 22%
Researcher 4 22%
Unspecified 3 17%
Other 3 17%
Student > Ph. D. Student 2 11%
Other 2 11%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 17%
Unspecified 3 17%
Medicine and Dentistry 3 17%
Agricultural and Biological Sciences 2 11%
Economics, Econometrics and Finance 2 11%
Other 5 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2014.
All research outputs
#7,017,515
of 12,434,754 outputs
Outputs from Diabetes Therapy
#145
of 415 outputs
Outputs of similar age
#96,817
of 233,466 outputs
Outputs of similar age from Diabetes Therapy
#3
of 17 outputs
Altmetric has tracked 12,434,754 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 415 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,466 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.